14 Plaza Drive
United States - Map
AngioDynamics, Inc. designs, manufactures, and sells medical, surgical, and diagnostic devices. The company offers manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; and venous products, including laser system products used in endovascular laser procedures to treat superficial venous diseases, as well as sclerosing drugs that are used in the treatment of small uncomplicated varicose veins of the lower extremities. It also provides angiographic catheters and guidewires used during peripheral vascular interventional procedures; venous drainage cannula intended for use as a venous drainage cannula during extracorporeal bypass and cardiopulmonary bypass circuit intended for use in procedures requiring extracorporeal circulatory support; and drainage products that drain abscesses and other fluid pockets. In addition, the company offers thrombolytic catheters that are used to deliver thrombolytic agents; micro access sets for minimally-invasive procedures; dialysis catheters that provide short and long-term vascular access for dialysis patients; and peripherally inserted central catheters, implantable ports, and central venous catheters. Further, it provides radiofrequency ablation products, soft tissue surgical ablation products, and microwave ablation products. The company markets and sells its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, and interventional and surgical oncologists directly and through distributors in the United States and internationally. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
|AngioDynamics Inc.’s ISS Governance QuickScore as of Oct 1, 2014 is 8. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 10; Compensation: 5.|
|Brought to you by Institutional Shareholder Services (ISS)|
|Mr. Joseph M. DeVivo ,
Chief Exec. Officer, Pres and Director
|Mr. Mark T. Frost ,
Chief Financial Officer, Exec. VP and Treasurer
|Mr. Mark A. Stephens ,
Sr. VP of Admin.
|Mr. John Soto ,
Chief Commercial Officer and Exec. VP
|Mr. Stephen A. Trowbridge ,
Sr. VP, Gen. Counsel and Assistant Sec.
|Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|